GLP-1 and Insurance: Paying for Treatment

The Cost Landscape

Brand-name GLP-1 medications are among the most expensive prescription drugs on the market. Without insurance or discount programs, patients face staggering monthly costs: Wegovy (semaglutide for weight loss) runs approximately $1,350 per month, Zepbound (tirzepatide for weight loss) costs around $1,060 per month, and Ozempic (semaglutide for diabetes) carries a list price near $935 per month. Mounjaro (tirzepatide for diabetes) falls in a similar range at roughly $1,050 per month.

Why are these medications so expensive? The answer comes down to three factors. First, pharmaceutical companies invest billions in research and development — Novo Nordisk spent over a decade and hundreds of millions of dollars developing semaglutide through multiple clinical trials. Second, patent protection gives manufacturers exclusive rights to produce and sell these drugs, eliminating price competition for years. Third, the limited number of GLP-1 manufacturers (primarily Novo Nordisk and Eli Lilly) means there's little market pressure to lower prices. Until generic versions become available — which likely won't happen until the late 2020s or early 2030s — brand-name prices will remain high. For a deeper look at how these medications work, see our guide to GLP-1 basics.

Insurance Coverage for Brand-Name GLP-1s

Insurance coverage for GLP-1 medications is inconsistent and often frustrating. Many commercial health plans explicitly exclude weight loss medications from their formularies, categorizing them as "lifestyle" drugs rather than medically necessary treatments. Even plans that do cover GLP-1s may only approve them for Type 2 diabetes management — not for obesity or weight loss — meaning a patient with a BMI of 35 but no diabetes diagnosis may be denied coverage entirely.

For patients whose plans do offer coverage, the process is rarely straightforward. Most insurers require prior authorization, a process where your doctor must submit clinical documentation proving medical necessity. This can take days or weeks and may be denied on the first attempt. Many plans also enforce step therapy, requiring you to try (and fail on) cheaper weight loss interventions — such as lifestyle counseling, older medications like phentermine, or even bariatric surgery consultations — before they'll approve a GLP-1 prescription.

If your prior authorization is denied, you have the right to appeal. The appeals process typically involves your provider submitting additional medical records, peer-reviewed studies supporting GLP-1 treatment, and sometimes a peer-to-peer review call with an insurance company physician. While appeals can succeed, they add weeks or months of delay. Coverage also varies significantly by employer plan — two people with the same insurance carrier may have entirely different GLP-1 coverage depending on what their employer chose to include. Even with insurance approval, copays for brand-name GLP-1s often range from $200 to $500 per month, making the medication a significant financial commitment regardless.

Manufacturer Savings Programs

Both Novo Nordisk and Eli Lilly offer savings card programs designed to reduce out-of-pocket costs for eligible patients. Novo Nordisk's savings card for Wegovy can reduce copays to as low as $0 for qualifying patients with commercial insurance, while Eli Lilly's savings card for Zepbound has offered similar introductory pricing. These programs can be a significant help — some patients report saving $500 or more per month with an active savings card.

However, there are important limitations to understand. Eligibility typically requires commercial (employer-sponsored or marketplace) insurance — patients with Medicare, Medicaid, Tricare, or other government-funded insurance programs are almost always excluded. The savings cards often have annual caps (for example, a maximum benefit of $150 per fill or a $1,500 annual limit), and many programs have time limits, offering reduced pricing for only 12 to 24 months before the benefit expires. Manufacturers can also change or discontinue these programs with little notice. Patients should think of savings cards as a helpful short-term bridge rather than a permanent solution. For a broader comparison of your medication options, see our compounded vs. brand-name guide.

HSA and FSA: Your Best Friend for Compounded GLP-1s

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are among the most effective tools for paying for GLP-1 treatment — especially compounded medications. An HSA is a tax-advantaged account available to individuals with high-deductible health plans (HDHPs). Contributions are pre-tax, growth is tax-free, and withdrawals for qualified medical expenses are tax-free — a triple tax advantage. An FSA is similar but offered through your employer, with pre-tax contributions that can be used for medical expenses during the plan year (use-it-or-lose-it rules typically apply, with some employers offering a small rollover or grace period).

Compounded GLP-1 medications qualify as eligible HSA/FSA expenses because they are prescribed by a licensed healthcare provider for a legitimate medical condition (obesity, weight management, or metabolic health). The IRS considers any medication that requires a prescription to be a qualified medical expense, regardless of whether it's a brand-name or compounded product.

Using pre-tax HSA/FSA dollars effectively gives you a 20–35% discount on your medication cost (depending on your tax bracket), making already-affordable compounded medications even more accessible. If you're considering a telehealth provider, read our guide on preparing for your first telehealth consultation.

The Compounding Cost Advantage

For patients without comprehensive insurance coverage, compounded GLP-1 medications represent the most significant cost savings available. Compounded semaglutide is available for as low as $99 per month, and compounded tirzepatide starts as low as $149 per month from providers like CoreAge Rx (visit their website for current pricing and available promotions). That's a savings of 85–93% compared to brand-name list prices.

Why are compounded medications so much cheaper? Compounding pharmacies don't bear the billions in R&D and clinical trial costs that brand manufacturers do. They produce medications using the same active pharmaceutical ingredients but operate in a competitive market with dozens of compounding pharmacies vying for patients — competition that drives prices down. Many compounding pharmacies also offer all-inclusive pricing that bundles the medication, provider consultation, and shipping into one transparent price, unlike brand-name pathways where you might face separate charges for the doctor visit, the prescription, shipping, and injection supplies. For a detailed look at how to evaluate compounding pharmacies, see our guide to choosing a compounding pharmacy.

Medicare and Medicaid Considerations

Medicare Part D has historically excluded coverage for weight loss medications, classifying them alongside cosmetic drugs and fertility treatments as optional. This exclusion left millions of Medicare beneficiaries without affordable access to GLP-1 treatments. However, recent legislative and regulatory changes have begun to shift this landscape. The Treat and Reduce Obesity Act and similar proposals have pushed for Medicare coverage of anti-obesity medications, and some Medicare Advantage plans have started including GLP-1 coverage as a supplemental benefit — though this varies widely by plan and region.

Medicaid coverage for GLP-1 medications varies dramatically by state. Some states cover GLP-1s for diabetes management but not for weight loss, while others have expanded coverage to include obesity treatment. Patients on Medicaid should contact their state Medicaid office or managed care plan directly to understand what's covered. Regarding compounded medications, Medicare and Medicaid generally do not cover compounded drugs, though there are limited exceptions for certain compounds prepared by 503B outsourcing facilities. For most Medicare and Medicaid patients, paying out of pocket for compounded GLP-1s remains the most practical path to affordable treatment.

Tax Deductions for Medical Expenses

Even if you're paying entirely out of pocket, the IRS offers a potential benefit. Medical expenses that exceed 7.5% of your adjusted gross income (AGI) are tax-deductible when you itemize deductions on your federal tax return. GLP-1 medications — both brand-name and compounded — qualify as deductible medical expenses when prescribed by a licensed healthcare provider for a medical condition.

For example, if your AGI is $60,000, you can deduct medical expenses exceeding $4,500 (7.5% of $60,000). If your total qualifying medical expenses for the year — including GLP-1 medication, provider consultations, lab work, and other healthcare costs — total $6,500, you could deduct $2,000 from your taxable income. To take advantage of this deduction, keep meticulous records: pharmacy receipts, provider invoices, prescription records, and any documentation of your medical diagnosis. Consult a tax professional to determine whether itemizing makes sense for your situation.

Cost Comparison: All Your Options

Here's a side-by-side look at the monthly cost of GLP-1 treatment across different payment pathways. These ranges reflect typical pricing as of early 2026 and may vary based on your specific plan, pharmacy, and dosage.

For detailed medication information, see our guides to semaglutide and tirzepatide.

Tips for Minimizing Out-of-Pocket Costs

• Compare multiple pharmacies — Pricing varies significantly between compounding pharmacies. Check at least three providers before committing. Our pharmacy directory makes it easy to compare options side by side.
• Ask about multi-month discounts — Many pharmacies offer 10–20% discounts when you purchase a two- or three-month supply upfront. This reduces your per-month cost and guarantees uninterrupted treatment.
• Use HSA/FSA funds — As covered above, paying with pre-tax dollars effectively gives you a 20–35% discount depending on your tax bracket. If your employer offers an FSA, max out your contribution during open enrollment.
• Check for promotional pricing — Compounding pharmacies frequently run first-month specials, referral discounts, and seasonal promotions. Sign up for email lists and check patient reviews to learn about current deals.
• Consider combination formulations — Some pharmacies offer GLP-1 medications combined with B12, NAD+, or other compounds at little to no additional cost compared to the base medication. These combinations can provide added value — energy support, enhanced metabolism — without increasing your monthly spend.
• Review your insurance plan annually — GLP-1 coverage is evolving rapidly. During open enrollment, check whether new plan options include anti-obesity medication coverage. Some employers are adding this benefit in response to employee demand.
• Bundle telehealth and medication — Providers that include the consultation fee in the medication price save you the cost of a separate doctor visit, which can run $100–$300 without insurance.

Questions to Ask Your Provider

Whether you're seeing your primary care physician or a telehealth provider, come prepared with these questions to make the most informed financial decision:

The cost of GLP-1 treatment doesn't have to be a barrier to better health. By understanding your options — from insurance appeals to HSA/FSA funds to affordable compounded alternatives — you can find a path that fits your budget. Browse our verified pharmacy listings to start comparing pricing, or read real patient reviews to see what others are paying.